Bax N.A.M. et al., Cardiomyocyte progenitor cells produce and remodel matrix during in vitro differentiation. J Mol Cell Cardiol 2012;DOI 10.1016/j.yjmcc.2012.07.003
Fioretta ES, Fledderus J, Burakovska E, Baaijens FPT, Verhaar M, Bouten CVC. Polymer-based scaffold designs for in situ vascular tissue engineering: controlling recruitment and differentiation behavior of ECFCs. Macromol Biosci 2012;12:577-590.
Van Geemen D, Driessen-Mol A, Grootzwagers LGM, Riem Vis PW, Baaijens FPT, Bouten CVC. Variation in tissue outcome of ovine and human engineered heart valve constructs: relevance for tissue engineering. Reg Med 2012;7:59-70.
Bouten CVC, Dankers PYW, Driessen-Mol A, Pedron S, Brizard AM, Baaijens FPT. Substrates for cardiovascular tissue engineering. Adv Drug Deliv Rev. 2011;63(4-5):221-241.
Riem Vis PW, Kluin J, Sluijter JPG, van Herwerden LA, Bouten CVC. Environmental regulation of valvulogenesis: implications for tissue engineering. Eur J CardioThoracic Surgery 2011;39(1):8-17.
Balguid A, Mol A, van Vlimmeren MAA, Baaijens FPT, Bouten CVC. Hypoxia induced near-native mechanical properties of engineered heart valve tissue. Circulation 2009;119:290-297.
Hjortnaes J, Bouten CVC, van Herwerden LA, Grundeman PM, Kluin J. Translating autologous heart valve tissue engineering form bench to bed. Tissue Engineering Part B Rev 2009;15(3):307-317.
Rubbens MP, Mol A, Boerboom RA, Bank RA, Baaijens FPT, Bouten CVC. Intermittent straining accelerates the development of tissue properties in engineered heart valve tissue. Tissue Engineering Part A 2009;15(5): 999-1008.
Gawlitta D, Boonen KJM, Oomens CWJ, Baaijens FPT, Bouten CVC. The influence of serum-free culturing on skeletal muscle development in a tissue-engineered model. Tissue Engineering Part A 2008;1:161-171.
Boerboom RA, Nash-Krahn K, Megens RTA, van Zandvoort MAMJ, Merkx M, Bouten CVC. High resolution imaging of collagen organization and synthesis using a versatile collagen specific probe. J Structural Biol 2007;159: 392-399.